Case number 1:20-cv-01496
Merck Sharp & Dohme Corp. v. Ajanta Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 22, 2021 | 55 | Redacted Document (30) Docket Text: REDACTED VERSION of [46] Proposed Pretrial Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/23/2021 (nms). |
| Sep 15, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [53]. (nms) |
| Sep 15, 2021 | 54 | Consent Judgment (4) |
| Sep 15, 2021 | 54 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # (1) Consent Judgment)(nms) |
| Sep 15, 2021 | 53 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT between Plaintiff and Ajanta Pharma Limited and Ajanta Pharma USA Inc.. Signed by Judge Richard G. Andrews on 9/15/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-01496-RGA(nms) |
| Sep 15, 2021 | 52 | Proposed Consent Judgment (4) Docket Text: PROPOSED Consent Judgment as to Defendants Ajanta Pharma Limited and Ajanta Pharma USA Inc., by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/15/2021 (nms). |
| Sep 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 179 in 19-cv-313-RGA; D.I. 50 in 20-cv-1496-RGA: D.I. 111 in 20-cv-1099-RGA: D.I. 575 in 19-md-2902-RGA; D.I. 158 in 19-cv-314-RGA: 115 in 20-cv-749-RGA: 75 in 20-cv-815-RGA; D.I. 187 in 19-cv-319-RGA: D.I. 93 in 20-cv-847-RGA: D.I. 169 in 19-cv-312-RGA; D.I. 106 in 20-cv-949-RGA) STIPULATION TO EXTEND TIME the Deadline to Submit a Redacted Version of the Proposed Joint Pretrial Order to September 17, 2021. Signed by Judge Richard G. Andrews on 9/10/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Sep 10, 2021 | 51 | Order (2) Docket Text: ORDER AFTER PRETRIAL CONFERENCE (see Order for further details). Signed by Judge Richard G. Andrews on 9/10/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Sep 10, 2021 | N/A | Pretrial Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Pretrial Conference held on 9/10/2021. Counsel for Plaintiff: D. Silver, A. Joyce. Counsel for Defendants: A. Gaza, J. Phillips, E. Ormerod, D. Gattuso. A 3 day Bench Trial is set to begin on 10/4/2021 in Courtroom 6A. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Sep 10, 2021 | 50 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION and Proposed Order to Extend Time to Submit a Redacted Version of the Proposed Joint Pretrial Order to September 17, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/10/2021 (nms). |
| Sep 9, 2021 | N/A | Remark (0) Docket Text: Remark: The public may access the hearing scheduled for 9/10/2021, at 8:15 a.m. by dialing the following phone number: +1 202-503-1666, then enter Conference ID: 258126659#. The dial-in information provides listening capabilities only. Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Sep 8, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Pretrial Conference set for 9/10/2021 will now begin at 8:15 AM and will be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 12:00 PM on 9/9/2021. Ordered by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-md-02902-RGA et al.(lak) |
| Sep 8, 2021 | 48 | Certification for David M. Krinsky (1) |
| Sep 8, 2021 | 48 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for David M. Krinsky)(Silver, Daniel) |
| Sep 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (185 in 19-cv-319-RGA; 73 in 20-cv-815-RGA; 12 in 21-cv-824-RGA; 48 in 20-cv-1496-RGA; 156 in 19-cv-314-RGA; 572 in 19-md-2902-RGA; 104 in 20-cv-949-RGA; 6 in 21-cv-1172-RGA; 91 in 20-cv-847-RGA; 114 in 20-cv-749-RGA; 35 in 21-cv-315-RGA; 109 in 20-cv-1099-RGA; 167 in 19-cv-312-RGA; 8 in 21-cv-1173-RGA; 177 in 19-cv-313-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Sep 7, 2021 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. ยง 282 [CONFIDENTIAL] filed by Sandoz Inc..(Gattuso, Dominick) |
| Aug 23, 2021 | 45 | Order (3) Docket Text: STATMENT: Regarding impasse on "Statement of Contested Issues of Fact" for inclusion in the proposed pretrial order (see Statement for further details). Signed by Judge Richard G. Andrews on 8/23/2021. (nms) |
| Aug 19, 2021 | 44 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., responding to Merck's Letter. (Gattuso, Dominick) Modified on 8/21/2021 (nms). |
| Aug 19, 2021 | 43 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding the Submission of the Pretrial Order. (Silver, Daniel) |
| Aug 11, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Vanessa O. Omoroghomwan for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00847-RGA et al.(srs) |
| Jul 20, 2021 | 42 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Leonard J. Chyall, Ph. D. on July 23, 2021 filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jul 19, 2021 | 41 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of David MacMillan on July 21, 2021 filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David) |
| Jul 12, 2021 | 40 | Notice (Other) (2) Docket Text: NOTICE of Remote Deposition of Graham Buckton, Ph.D. by Merck Sharp & Dohme Corp. (Silver, Daniel) |
| Jul 8, 2021 | 39 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Allan Myerson on July 13, 2021, filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David) Modified on 7/9/2021 (nms). |
| Jul 2, 2021 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - T/C Status Conference held on 7/2/2021. Counsel for Plaintiffs: A. Joyce, A. Gaza, E. Ormerod. Counsel for Defendants: K. Dorsney, J. Phillips, D. Gattuso. The 9/10/2021 pretrial conference shall cover invalidity only. A separate pretrial conference will be scheduled to cover infringement. (Court Reporter Stacy Ingram.) Associated Cases: 1:19-md-02902-RGA et al.(lak) |
| Jul 2, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The 9/10/2021 pretrial conference will cover invalidity only. A separate pretrial conference will be scheduled to cover infringement. Ordered by Judge Richard G. Andrews on 7/2/2021. Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Jun 29, 2021 | 37 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding dial-in information for July 2, 2021 status conference. (Silver, Daniel) Modified on 6/30/2021 (nms). |
| Jun 24, 2021 | 36 | Certification for Vanessa O. Omoroghomwan (1) |
| Jun 24, 2021 | 36 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Vanessa O. Omoroghomwan)(Silver, Daniel) |
| Jun 24, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (75 in 20-cv-847-RGA; 36 in 20-cv-1496-RGA; 96 in 20-cv-749-RGA; 166 in 19-cv-319-RGA; 78 in 20-cv-949-RGA; 82 in 20-cv-1099-RGA; 144 in 19-cv-314-RGA; 163 in 19-cv-313-RGA; 30 in 21-cv-315-RGA; 189 in 19-cv-1489-RGA; 10 in 21-cv-824-RGA; 155 in 19-cv-312-RGA; 61 in 20-cv-815-RGA) MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 6/24/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Jun 7, 2021 | 35 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendants' Reply Expert Report of Leonard J. Chyall, Ph.D. Concerning Invalidity of Claims 1-3, 17, 19, and 21-23 of U.S. Patent No. 7,326,70 [CONFIDENTIAL]; and (ii) the Reply Expert Report of Graham Buckton, Ph.D., D.Sc. [CONFIDENTIAL] filed by Sandoz Inc..(Gattuso, Dominick) |
| May 25, 2021 | 34 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jeffrey Ho as co-counsel.. (Silver, Daniel) |
| May 11, 2021 | 33 | IPR Decision (77) |
| May 11, 2021 | 33 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding IPR Decision. (Attachments: # (1) IPR Decision)(Silver, Daniel) |
| Apr 19, 2021 | 32 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of (1) Responsive Report of Zachary T. Bloomgarden, M.D. Regarding Validity; (2) Responsive Report of David MacMillan, Ph.D. Regarding Validity; (3) Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validty of U.S. Patent No. 7,326,708; (4) Responsive Report of Adam J. Matzger, Ph.D. Regarding Validity of the 708 Patent; and (5) Confidential Addendum to the Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validity of U.S. Patent No. 7,326,708 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Mar 3, 2021 | 31 | Order (5) Docket Text: SO ORDERED Granting (63 in 20-cv-949-RGA; 63 in 20-cv-847-RGA; 416 in 19-md-2902-RGA; 151 in 19-cv-313-RGA; 138 in 19-cv-314-RGA; 177 in 19-cv-1489-RGA; 30 in 20-cv-1496-RGA; 68 in 20-cv-749-RGA; 65 in 20-cv-1099-RGA; 143 in 19-cv-312-RGA; 55 in 20-cv-815-RGA; 151 in 19-cv-319-RGA) Stipulation and Proposed Order Regarding Corrected Asserted Claims. Signed by Judge Richard G. Andrews on 3/3/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Mar 3, 2021 | 30 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order Regarding Corrected Asserted Claims by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) |
| Feb 22, 2021 | 29 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of All Defendants' Opening Expert Report of Graham Buckton, Ph.D., D.Sc. filed by Sandoz Inc..(Gattuso, Dominick) |
| Feb 22, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynges Judicial Administrator to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 2/22/21. (cak) |
| Feb 19, 2021 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Leonard J. Chyall, Ph.D. Concerning Invalidity of Claims 1-3, 17, 19 and 21-23 of U.S. Patent No. 7,326,708 filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Feb 10, 2021 | 26 | Certificate of Correction (1) |
| Feb 10, 2021 | 26 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Certificate of Correction. (Attachments: # (1) Certificate of Correction)(Silver, Daniel) |
| Feb 1, 2021 | 25 | Order (4) Docket Text: SO ORDERED Granting (D.I. 24 in 20-cv-1496-RGA; D.I. 377 in 19-md-2902-RGA) Stipulation and Proposed Order Regarding Infringement. Signed by Judge Richard G. Andrews on 1/29/2021. Associated Cases: 1:20-cv-01496-RGA, 1:19-md-02902-RGA(nms) |
| Jan 29, 2021 | 24 | Stipulation (4) Docket Text: STIPULATION and Proposed Order Regarding Infringement by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) |
| Jan 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (23 in 20-cv-1496-RGA; 51 in 20-cv-949-RGA; 374 in 19-md-2902-RGA; 138 in 19-cv-312-RGA; 54 in 20-cv-847-RGA; 141 in 19-cv-319-RGA; 50 in 20-cv-815-RGA; 52 in 20-cv-749-RGA; 144 in 19-cv-313-RGA; 148 in 19-cv-311-RGA; 170 in 19-cv-1489-RGA; 64 in 20-cv-776-RGA; 132 in 19-cv-314-RGA; 142 in 19-cv-347-RGA; 50 in 20-cv-1099-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey Ho, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 1/25/2021. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Jan 25, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jeffrey G. Ho for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA et al.(kmd) |
| Jan 22, 2021 | 23 | Certification of Jeffrey Ho (1) |
| Jan 22, 2021 | 23 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey Ho - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification of Jeffrey Ho)(Silver, Daniel) |
| Jan 11, 2021 | 22 | Order (2) Docket Text: TRIAL SCHEDULING ORDER: Bench trials with Plaintiff and Defendants Ajanta (C.A. 20-1496-RGA), Apotex (C.A. 19-313-RGA; 20cv749-RGA) and Aurobindo (C.A. 20-949-RGA; C.A. 20-1099-RGA) are set to start at 8:30 am on November 22, 2021, and end on November 24, 2021. The exact order for which case will be proceeding first, second, and third is yet to be determined. Bench trials with Plaintiff and Defendants Dr. Reddys (C.A. 20-847-RGA), Lupin (C.A. 19-347-RGA; C.A. 20-776-RGA) and Zydus (C.A. 19-314-RGA) are set to start at 8:30 am on December 27, 2021, and end on December 29, 2021. The exact order for which case will be proceeding first, second, and third is yet to be determined. A bench trial between Plaintiff and Defendant Sun (C.A. 19-319-RGA) will start at 8:30 am on January 3, 2022, and conclude on January 4, 2022. A telephone status conference is set for July 2, 2021, at 8:30 am. Plaintiffs local counsel shall coordinate the call and file the dial-in information no later than 48 hours before the conference. Signed by Judge Richard G. Andrews on 1/11/2021. Associated Cases: 1:19-cv-00311-RGA et al.(nms) Modified on 1/12/2021 (nms). |
| Jan 8, 2021 | 21 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding a status update regarding infringement trials. (Silver, Daniel) Modified on 1/8/2021 (nms). |
| Jan 8, 2021 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Ajanta Pharma Limited and Ajanta Pharma USA Inc.'s [CONFIDENTIAL] Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures and Ajanta Pharma Limited and Ajanta Pharma USA Inc.'s [CONFIDENTIAL] Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David) |
| Jan 8, 2021 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Jan 6, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Dec 30, 2020 | 18 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Dec 28, 2020 | 17 | Scheduling Order (10) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/12/2021. Amended Pleadings due by 3/12/2021. Fact Discovery completed by 3/12/2021. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 12/28/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-01496-RGA(nms) |
| Dec 23, 2020 | 16 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. , regarding certificate of correction. (Silver, Daniel) Modified on 12/23/2020 (nms). |
| Dec 22, 2020 | 15 | Proposed Order (10) Docket Text: PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 12/22/2020 (nms). |
| Dec 2, 2020 | 14 | Abramowitz Pro Hac Certification (1) |
| Dec 2, 2020 | 14 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz and Carolyn A. Blessing - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: # (1) Abramowitz Pro Hac Certification, # (2) Blessing Pro Hac Certification)(Bilson, David) |
| Dec 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz and Carolyn A. Blessing, filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. Signed by Judge Richard G. Andrews on 12/2/2020. (nms) |
| Dec 2, 2020 | 14 | Blessing Pro Hac Certification (1) |
| Dec 1, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Michael J. Gaertner and Christopher J. Cassella for Ajanta Pharma Limited and Ajanta Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Dec 1, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner and Christopher J. Cassella, filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. Signed by Judge Richard G. Andrews on 12/1/2020. (nms) |
| Nov 30, 2020 | 13 | Cassella Pro Hac Certification (1) |
| Nov 30, 2020 | 13 | Gaertner Pro Hac Certification (1) |
| Nov 30, 2020 | 13 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner and Christopher J. Cassella - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: # (1) Certification, # (2) Certification)(Bilson, David) Modified on 12/1/2020 (nms). |
| Nov 24, 2020 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ajanta Pharma Limited. (Phillips, John) |
| Nov 24, 2020 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ajanta Pharma Limited for Ajanta Pharma USA Inc. filed by Ajanta Pharma USA Inc.. (Phillips, John) |
| Nov 24, 2020 | 10 | Answer to Complaint (14) Docket Text: ANSWER to [1] Complaint and Affirmative Defenses, by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Phillips, John) Modified on 11/25/2020 (nms). |
| Nov 23, 2020 | 9 | Order (9) Docket Text: SO ORDERED Granting Stipulation and Proposed Order Regarding Authenticity of Documents. Signed by Judge Richard G. Andrews on 11/23/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Nov 20, 2020 | 8 | Stipulation (9) Docket Text: STIPULATION and Proposed Order Regarding Authenticity of Documents, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2020 (nms). |
| Nov 12, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Nov 6, 2020 | 7 | Declaration (2) Docket Text: DECLARATION of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/12/2020 (nms). |
| Nov 4, 2020 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Ajanta Pharma Limited, Ajanta Pharma USA Inc. - Magistrate Consent Notice to Pltf. (Filing fee $400, receipt number ADEDC-3311422.) - filed by Merck Sharp & Dohme Corp. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(kmd) |
| Nov 4, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Nov 4, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. - filed by Merck Sharp & Dohme Corp. (kmd) |
| Nov 4, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (kmd) |
| Nov 4, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: no earlier than 10/5/2020. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: no earlier than 4/5/2023. (kmd) |
| Nov 4, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Nov 4, 2020 | 1 | Civil Cover Sheet (3) |
| Nov 4, 2020 | 1 | Exhibit A (17) |
| Nov 4, 2020 | 1 | Complaint* (1) |
